Osteoporosis is a disease that causes a gradual loss of bone mass. Over time, bones become less and less dense, making them more and more fragile. At an advanced stage of the disease, the slightest stress or trauma can result in a fracture.
In men, the consequences of a hip fracture due to osteoporosis are often more serious than in women, including a higher risk of death.
Bone densitometry is a technology used to precisely measure bone density. The results of your bone mineral density (BMD) test are compared against the average results of young adults of the same gender and ethnic group, to assess the level of bone loss.
All men age 65 or older should undergo screening for osteoporosis. However, screening can begin earlier, starting at age 50, in men whose risk factors for developing osteoporosis are greater:
If you have any questions about osteoporosis and how it is treated, ask your pharmacist.
The pharmacy services presented in this section are offered by pharmacist owners who are affiliated with PROXIM. The pharmacists are solely responsible for the professional activities carried out during the practice of pharmacy.
The information contained herein is provided for informational purposes only and is not intended to provide complete information on the subject matter or to replace the advice of a health professional. This information does not constitute medical consultation, diagnosis or opinion and should not be interpreted as such. Please consult your health care provider if you have any questions about your health, medications or treatment.
